BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 26384802)

  • 21. Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis.
    Petrelli F; Coinu A; Cabiddu M; Ghilardi M; Vavassori I; Barni S
    Eur Urol; 2014 Feb; 65(2):350-7. PubMed ID: 23849998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of pathologic stages on postmastectomy radiation therapy in breast cancer receiving neoadjuvant chemotherapy and total mastectomy: A Cancer Database Analysis.
    Zhang J; Lu CY; Chen CH; Chen HM; Wu SY
    Breast; 2020 Dec; 54():70-78. PubMed ID: 32947148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06.
    Deutsch M; Land SR; Begovic M; Wieand HS; Wolmark N; Fisher B
    Cancer; 2003 Oct; 98(7):1362-8. PubMed ID: 14508821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.
    Kuerer HM; Newman LA; Buzdar AU; Dhingra K; Hunt KK; Buchholz TA; Binkley SM; Strom EA; Ames FC; Ross MI; Feig BW; McNeese MD; Hortobagyi GN; Singletary SE
    Cancer J Sci Am; 1998; 4(4):230-6. PubMed ID: 9689981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of isolated tumor cells on loco-regional recurrence in breast cancer patients treated with breast-conserving treatment or mastectomy without post-mastectomy radiation therapy.
    Keruakous AR; Sadek BT; Shenouda MN; Niemierko A; Abi Raad RF; Specht M; Smith BL; Taghian AG
    Breast Cancer Res Treat; 2014 Jul; 146(2):365-70. PubMed ID: 24952906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
    Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postmastectomy radiation therapy following pathologic complete nodal response to neoadjuvant chemotherapy: A prelude to NSABP B-51?
    Haque W; Singh A; Verma V; Schwartz MR; Chevli N; Hatch S; Desai M; Butler EB; Arentz C; Farach A; Teh BS
    Radiother Oncol; 2021 Sep; 162():52-59. PubMed ID: 34214615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing locoregional control and survival for women with breast cancer: a review of current developments in postmastectomy radiotherapy.
    Truong PT; Woodward WA; Buchholz TA
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):205-16. PubMed ID: 16445373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
    Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Hortobagyi GN; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):351-7. PubMed ID: 15890574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
    Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
    Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?
    Daveau C; Stevens D; Brain E; Berges O; Villette S; Moisson P; Gardner M; De la Lande B; Lasry S; Labib A; Le Scodan R
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):337-42. PubMed ID: 20171795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update.
    Recht A; Comen EA; Fine RE; Fleming GF; Hardenbergh PH; Ho AY; Hudis CA; Hwang ES; Kirshner JJ; Morrow M; Salerno KE; Sledge GW; Solin LJ; Spears PA; Whelan TJ; Somerfield MR; Edge SB
    Pract Radiat Oncol; 2016; 6(6):e219-e234. PubMed ID: 27659727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel lymph node biopsy is a reliable method for lymph node evaluation in neoadjuvant chemotherapy-treated patients with breast cancer.
    Koslow SB; Eisenberg RE; Qiu Q; Chen Z; Swistel A; Shin SJ
    Am Surg; 2014 Feb; 80(2):171-7. PubMed ID: 24480218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of patients with locally advanced breast cancer.
    Lee MC; Newman LA
    Surg Clin North Am; 2007 Apr; 87(2):379-98, ix. PubMed ID: 17498533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
    Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiotherapy Issues After Neoadjuvant Chemotherapy.
    Mak KS; Harris JR
    J Natl Cancer Inst Monogr; 2015 May; 2015(51):87-9. PubMed ID: 26063895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is postmastectomy radiotherapy necessary for breast cancer patients with clinically node-positive downstaging to ypN0 after neoadjuvant chemotherapy?
    Tan CF; Wang J; Zhong XR; Dai ZL; Xiang ZZ; Zeng YY; Wei XY; Xu NY; Liu L
    Breast Cancer Res Treat; 2024 Jul; 206(1):45-56. PubMed ID: 38616207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes.
    Yin H; Qu Y; Wang X; Ma T; Zhang H; Zhang Y; Li Y; Zhang S; Ma H; Xing E; Liu X; Xu Q
    Oncotarget; 2017 Jul; 8(30):49564-49573. PubMed ID: 28484094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.